| AFFYMETRIX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Affymetrix Inc. | |
| | |
|
NEW ORLEANS, Jan. 14, 2016 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Affymetrix Inc. ("Affymetrix" or the "Company") (AFFX) to Thermo Fisher Scientific Inc. (TMO). Under the terms of the proposed transaction, shareholders of Affymetrix will receive only $14.00 in cash for each share of Affymetrix that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. Kahn Swick & Foti, LLC 206 Covington St. Madisonville, LA 70447 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/affymetrix-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick--foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-affymetrix-inc-300204734.html
|
|
| |
ProfilIndicateurs de MarchéVALEUR : Projets & res.Communiqués de PresseRapport annuelRISQUE : Profile actifsContactez la cie |
Thermo Fisher est une société basée aux Etats-Unis D'Amerique. Thermo Fisher est cotée aux Etats-Unis D'Amerique. Sa capitalisation boursière aujourd'hui est 223,8 milliards US$ (209,0 milliards €). La valeur de son action a atteint son plus bas niveau récent le 15 novembre 2013 à 100,01 US$, et son plus haut niveau récent le 14 juin 2024 à 572,05 US$. Thermo Fisher possède 391 220 000 actions en circulation. |